Transdermal buprenorphine in children with cancer‐related pain

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Pediatric Blood & Cancer

• Publication date

  2009-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/pbc.21736PMID 18802942
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Practice Guidelines for Transdermal Opioids in Malignant Pain

  2012cited by this paper
• Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients

  2007cited by this paper
• [Buprenorphine in children. A clinical and pharmacological review].

  2006cited by this paper
• Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.

  2006cited by this paper
• Transdermal buprenorphine in cancer pain and palliative care

  2006cited by this paper
• Buprenorphineinsatz bei Kindern

  2006cited by this paper
• Paediatric cancer pain management using the WHO analgesic ladder — results of a prospective analysis from 2265 treatment days during a quality improvement study

  2006cited by this paper
• A comparison of the skin irritation potential of transdermal fentanyl versus transdermal buprenorphine in middle-aged to elderly healthy volunteers

  2006cited by this paper
• Patient work in end-stage heart failure: a prospective longitudinal multiple case study

  2006cited by this paper
• Transdermal buprenorphine in clinical practice – a post‐marketing surveillance study in 13 179 patients

  2005cited by this paper
• Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.

  2005cited by this paper
• Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.

  2004cited by this paper
• The transdermal revolution.

  2004cited by this paper
• Cancer pain management in children

  2004cited by this paper
• Buprenorphine TDS: use in daily practice, benefits for patients.

  2003cited by this paper
• Buprenorphine in a transdermal therapeutic system--a new option.

  2002cited by this paper
• Buprenorphine in a Transdermal Therapeutic System – A New Option

  2002cited by this paper
• Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.

  2002cited by this paper
• Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing.

  2001cited by this paper
• Cancer pain management in children

  2001cited by this paper
• Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome?

  2000cited by this paper
• Vincristine revisited.

  1999cited by this paper
• Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine.

  1998cited by this paper
• Vincristine disposition in children with acute lymphoblastic leukemia.

  1995cited by this paper
• The faces pain scale for the self‐assessment of the severity of pain experienced by children: Development, initial validation, and preliminary investigation for ratio scale properties

  1990cited by this paper
• Optimal sampling times for pharmacokinetic experiments

  1981cited by this paper

• Acute Tumor Lysis Syndrome: A Metabolic Emergency in Cancer Patients

  2021cites this paper
• Transdermal buprenorphine for pain management in children

  2021cites this paper
• Management of Oral Mucositis in Children With Malignant Solid Tumors

  2021cites this paper
• Narrative review of intrathecal drug delivery (IDD): indications, devices and potential complications

  2021cites this paper
• Pain Management in Childhood Leukemia: Diagnosis and Available Analgesic Treatments

  2020cites this paper
• Opioid Therapy for Pediatric Cancer Pain

  2020cites this paper
• Treatment and Long-Term Sequelae in Childhood Brain Tumors

  2020cites this paper
• Opioid Therapy in Infants, Children, and Adolescents

  2020cites this paper
• Sublingual Buprenorphine for Pediatric Cancer Pain: A Case Report and Review of the Literature.

  2020cites this paper
• Opioid transdermal delivery system: a useful method for pain management in children

  2020cites this paper
• Retrospective Review of the Use of Transdermal Buprenorphine Patches (Butrans) in a Pediatric Population

  2019cites this paper
• Pain Control in Latin America: The Optimized Role of Buprenorphine in the Treatment of Cancer and Noncancer Pain

  2019cites this paper
• A Scoping Review of Transdermal Buprenorphine Use for Non-surgical Pain in the Pediatric Population

  2019cites this paper
• Buprenorphine and pain treatment in pediatric patients: an update

  2018influential citation
• Sleep and fatigue in pediatric oncology: A review of the literature.

  2015cites this paper
• A CONCEPT ON THE DEVELOPMENT OF BUPRENORPHINE AUTOINJECTOR FOR SELF AND EMERGENCY ADMINISTRATION

  2015cites this paper
• Buprenorphine Analgesia in Chronic Pain

  2013cites this paper
• Efficacy and safety of transdermal buprenorphine in the management of children with cancer‐related pain

  2013cites this paper
• Use of buprenorphine in children with chronic pseudoobstruction syndrome: case series and review of literature.

  2012cites this paper
• Buprenorfina w plastrach. Szereg odpowiedzi na dręczące pytania

  2012cites this paper
• Buprenorphine TTS for children – a review of the drug’s clinical pharmacology

  2011cites this paper
• Current world literature.

  2010cites this paper
• Transdermal buprenorphine – a critical appraisal of its role in pain management

  2009cites this paper
• Chapter 8 - Opioid analgesics and narcotic antagonists

  2009cites this paper